COMP Career Catalyst - Treatment Planning in Nuclear Medicine and Brachytherapy'

The fifth COMP Career Catalyst session of the 2025/2026 year is open for registration! Join for an insightful seminar on ‘Treatment Planning in Nuclear Medicine and Brachytherapy': 

Date:  Tuesday, June 9th, 2026

Time:  8:00 AM - 9:30 AM PT / 11:00 AM - 12:30 PM ET

Location: Virtual (Zoom) Register Here: https://tinyurl.com/53m2aeh3 

This 1.5-hour virtual session will feature a demonstration of pre- and post-therapy dosimetry in Y90 liver radioembolization for nuclear medicine, along with a live showcase of how treatment plans are performed for brachytherapy. We’re thrilled to welcome two incredible speakers, each highly experienced with various clinical experiences in medical physics: 

• Dr. Julia Brosch-Lenz is the Head of the Section for quantitative molecular imaging and dosimetry at Universitätsklinikum Augsburg. She obtained her B.Sc. and M.Sc. degrees in physics from Ludwig Maximilian University (LMU) in Munich, Germany. During her PhD at the department of Nuclear Medicine at the LMU University Hospital, Munich, Germany, she focussed on 3D image-based dosimetry for internal radionuclide therapies with 90-Y SIRT and 177-Lu-PSMA. In 2019, she joined the Qurit lab as a visiting PhD student to work on Monte Carlo simulations for dosimetry of bone lesions in 177-Lu-PSMA therapy. She subsequently held positions as a postdoctoral fellow at BC Cancer in Vancouver, Canada, and as a medical physics research associate at Klinikum rechts der Isar in Munich, Germany, before serving as Lead Medical Physicist for Radiopharmaceutical Therapy Research at the Institute of Nuclear Medicine.
• Dr. Alexandra Rink is a board certified Medical Physicist at Princess Margaret Cancer Centre, an Associate Professor in the Departments of Radiation Oncology and Medical Biophysics, University of Toronto and a Clinician Scientist at the Princess Margaret Research Institute. She received her B.Sc. degree with honours in Chemical Physics from the College of Physical & Engineering Science at University of Guelph, and thereafter pursued a PhD in the Department of Medical Biophysics, University of Toronto. Her thesis, supported by the National Cancer Institute of Canada through a Terry Fox Foundation Research Studentship Award, focused on using polymer materials and optical fibre read-out in order to measure radiation dose remotely during the application of radiotherapy. Upon completion of graduate studies, Dr. Rink commenced a Medical Physics Residency program at Princess Margaret Cancer Centre with the Department of Radiation Oncology. In 2010, Dr. Rink joined the Image-Guided Interventional Radiotherapeutics for Prostate Cancer group as a Clinical Physics Fellow and in 2012 the Radiation Physics department as staff. She has been leading the brachytherapy physics group at the Princess Margaret Cancer Centre since 2013, helping implement image-guided interstitial treatments for gynaecological and prostate cancers. Dr. Rink has started her own lab in 2019, with research interest in quality improvement of brachytherapy through dosimetric measurements using in-vivo optical fibre technology, understanding and monitoring organ motion and filling, target and applicator uncertainty and the impact on dose distribution, and implant accuracy and efficiency.

Important: 

To ensure the security of our Zoom sessions, all participants are required to register using an institutional email address. Registrations made with non-institutional emails will be removed from the session. If you do not have an institutional email but would like to attend, please contact Fletcher (fletcher.barrett@ucalgary.ca) and Alaina (alainagiang.bui@mail.utoronto.ca)

See you there!

COMP Student Council